Evaluation of the efficacy and safety of luseogliflozin and changes in QOL
Latest Information Update: 04 Jun 2019
At a glance
- Drugs Luseogliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms Lusefi QOL study
- 07 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 15 Jul 2016 New trial record